NCT00022594 Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00022373 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Status UNKNOWN Phase PHASE3
NCT00022217 Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT00021424 Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00021333 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Status COMPLETED Phase PHASE2
NCT00021138 Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking Status COMPLETED Phase NA
NCT00021125 Radiation Therapy in Treating Patients With Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00021047 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT00020189 Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00019331 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Status COMPLETED Phase PHASE2
NCT00019201 Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer Status COMPLETED Phase NA
NCT00019110 Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer Status COMPLETED Phase PHASE1
NCT00017511 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00017498 Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck Status COMPLETED Phase PHASE2
NCT00017277 Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer Status TERMINATED Phase PHASE3
NCT00017173 S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat Status TERMINATED Phase PHASE2
NCT00015964 ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck Status COMPLETED Phase PHASE2
NCT00014456 Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00014404 Celecoxib in Treating Patients With Precancerous Lesions of the Mouth Status COMPLETED Phase PHASE2
NCT00014118 Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer Status COMPLETED Phase PHASE2